New research suggests GLP-1 users are buying fewer snacks and treats such as crisps and chocolate Business live – latest updates Weight-loss drugs are saving users’ households more than £400 a year on grocery bills, according to new research, which found use of GLP-1s has nearly tripled in the past two years to 1.9 million adults. Just more than 6.3% of households in Great Britain now include at l...
New research suggests GLP-1 users are buying fewer snacks and treats such as crisps and chocolate Business live – latest updates Weight-loss drugs are saving users’ households more than £400 a year on grocery bills, according to new research, which found use of GLP-1s has nearly tripled in the past two years to 1.9 million adults. Just more than 6.3% of households in Great Britain now include at least one GLP-1 user, according to the survey from Worldpanel by Numerator. This marks a sharp rise from 4.1% of households in 2025 and 2.3% in 2024. Continue reading...
halbergman/iStock via Getty Images Over the past few weeks, it's clear that a “risk off” attitude is taking hold in the stock market. Renewed war jitters in Iran, valuation concerns, and a consistently trembling macroeconomy have also reduced confidence in many consumer-facing businesses. Throughout this down cycle, Vail Resorts, Inc. ( MTN ), the largest chain operator of ski resorts in the world...
halbergman/iStock via Getty Images Over the past few weeks, it's clear that a “risk off” attitude is taking hold in the stock market. Renewed war jitters in Iran, valuation concerns, and a consistently trembling macroeconomy have also reduced confidence in many consumer-facing businesses. Throughout this down cycle, Vail Resorts, Inc. ( MTN ), the largest chain operator of ski resorts in the world, has continued to blame one external factor: the weather. Poor snowfall has impacted both pass sales and overall skier visitation. The company whose Epic Pass growth story and pricing power drove substantial COVID-era gains in the stock has faded substantially. Over the past year, Vail has lost ~15% of its value; over the past five years, the company has lost nearly 60% of its value. The key question for investors now is: Is Vail a lost cause or a potential rebound play? Data by YCharts I last wrote an article downgrading Vail to a neutral rating in March, when the stock was trading in the mid-$120s. Since then, Vail has traded in a range-bound fashion, but considering the deep guidance cut and decaying sales trends, I fear that conditions will only get worse for Vail. The company has no strategic actions (beyond cost-cutting) to address its declining pass sales; its blaming of poor snowfall may be legitimate, but it's unconvincing for investors who want to take a bet on a turnaround here. I'm downgrading my viewpoint on Vail back down to a Sell. Q3 recap Let's now go through fiscal Vail's Q3 (April quarter) results in greater detail. As a reminder, Q2 and Q3 comprise the critical winter season for Vail: the fact that it disappointed in the past two quarters means that we won't have evidence of a turnaround until next year. Vail’s revenue declined -7% y/y to $1.21 billion, which slightly beat Wall Street’s expectations of $1.20 billion. Revenue declines worsened two points relative to a -5% y/y decay in Q2. Vail Q3 Results (Vail Q3 Earnings Release) Again, the company is b...
The news that OpenAI ( OPENAI ) has confidentially filed for an initial public offering suggests that the floodgates to become a public company are “officially open,” Wedbush Securities said. “The floodgates for the IPO market are officially open with three major AI conglomerates set to go public later this year, but the race is starting to move faster as both Anthropic and OpenAI are expected to ...
The news that OpenAI ( OPENAI ) has confidentially filed for an initial public offering suggests that the floodgates to become a public company are “officially open,” Wedbush Securities said. “The floodgates for the IPO market are officially open with three major AI conglomerates set to go public later this year, but the race is starting to move faster as both Anthropic and OpenAI are expected to file their S-1s over the coming weeks that investors will be eagerly waiting for,” Wedbush analysts wrote in a note to clients. And with OpenAI and Anthropic ( ANTHRO ) racing to go public (Anthropic recently said it had confidentially filed to go public as well), the heat is on OpenAI and CEO Sam Altman, Wedbush added. “Altman continues to face competitive pressures from competitors like Anthropic to show that growth continues to accelerate and will maintain its current aggressive pace through the next decade,” the analysts explained. Despite the announcement, OpenAI did not provide a timeline for when it might go public. “We have not decided on timing yet; it may be a while because there are things we want to do that are likely easier as a private company,” the company said in a statement discussing its confidential filing. “But it's a complicated set of trade-offs, and this gives us the option to go public sooner if that ends up being best.” OpenAI crossed $25B in annualized revenue in February compared to $21.4B at the end of 2025. The company reached $1B in revenue within a year of ChatGPT's 2022 launch and is now generating $2B in revenue per month. In addition to OpenAI and Anthropic, SpaceX ( SPCX ), which merged with xAI in February, will make its public debut on June 12. SpaceX plans to sell 555.6M shares at $135 apiece, raising approximately $75B. At that price, the company would be valued at roughly $1.75T. More on OpenAI Wall Street Lunch: Hot Labor Market Defies Predictions Of AI-Led Job Losses OpenAI IPO Will Be An Artificial Intelligence Bubble Litmus Test ...
Panama7/iStock Editorial via Getty Images Shares of Dianthus Therapeutics ( DNTH ) fell more than 20% in the premarket on Wednesday after efficacy concerns prompted Sanofi ( SNY ) to halt a late-stage trial of riliprubart, an experimental therapy similar to the U.S. biotech’s lead asset, claseprubart. In a statement on Wednesday, the French drugmaker said that it would discontinue its MOBILIZE Pha...
Panama7/iStock Editorial via Getty Images Shares of Dianthus Therapeutics ( DNTH ) fell more than 20% in the premarket on Wednesday after efficacy concerns prompted Sanofi ( SNY ) to halt a late-stage trial of riliprubart, an experimental therapy similar to the U.S. biotech’s lead asset, claseprubart. In a statement on Wednesday, the French drugmaker said that it would discontinue its MOBILIZE Phase 3 study for riliprubart against a rare neurological condition called chronic inflammatory demyelinating polyneuropathy (CIDP). The decision came after an interim analysis revealed that riliprubart is unlikely to be sufficiently effective against CIDP, Sanofi ( SNY ) said, adding that given the setback, it will determine whether to continue other ongoing studies, including its VITALIZE Phase 3 study for the therapy. Similar to Dianthus’ ( DNTH ) claseprubart, which is also undergoing late-stage development, riliprubart is an antibody therapy designed to inhibit only the C1s complement protein in the classical complement pathway of the innate immune system. The New York-based company is on track to announce a topline readout from its Phase 3 CAPTIVATE trial for claseprubart in CIDP by the year-end. More on Dianthus Therapeutics, Sanofi, etc. Dianthus Therapeutics, Inc. (DNTH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript Dianthus Therapeutics: A Financed Autoimmune Platform With More Than One Way To Win Sanofi (SAN:CA) Q1 2026 Earnings Call Transcript Sanofi stops phase 3 study of riliprubart in rare nerve disease due to efficacy concerns Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
For working Americans with access to a 401(k), there's perhaps no easier way to save for retirement. You tell your employer how much money you want to contribute per year or per pay period, and that money gets deducted from your paychecks accordingly. Plus, if you're lucky, you may not only have access to a 401(k) plan but also a workplace match. That's free money you can invest alongside your own...
For working Americans with access to a 401(k), there's perhaps no easier way to save for retirement. You tell your employer how much money you want to contribute per year or per pay period, and that money gets deducted from your paychecks accordingly. Plus, if you're lucky, you may not only have access to a 401(k) plan but also a workplace match. That's free money you can invest alongside your own contributions. Image source: Getty Images. Continue reading
In this article XAU= @GC.1 XAG= AG @SI.1 BTC.CB= @GC26Q @SI26N HL AG Follow your favorite stocks CREATE FREE ACCOUNT Precious metals were among the assets firmly in negative territory on Wednesday, as fears about inflation and the Federal Reserve's interest rate path weighed on investor sentiment. By 7:05 a.m. ET, spot gold was down 2.4% to trade at around $ 4,161.63 an ounce. U.S. gold futures al...
In this article XAU= @GC.1 XAG= AG @SI.1 BTC.CB= @GC26Q @SI26N HL AG Follow your favorite stocks CREATE FREE ACCOUNT Precious metals were among the assets firmly in negative territory on Wednesday, as fears about inflation and the Federal Reserve's interest rate path weighed on investor sentiment. By 7:05 a.m. ET, spot gold was down 2.4% to trade at around $ 4,161.63 an ounce. U.S. gold futures also fell 2.2% to settle at $ 4,194.90/oz. Stock Chart Icon Stock chart icon Spot gold Meanwhile, spot silver was 2% lower at $64.01/oz, paring deeper losses seen earlier. Silver futures shed 1.6%. Stock Chart Icon Stock chart icon Spot silver Stocks and funds linked to gold and silver also fell in pre-market trading on Wednesday. The ProShares Ultra Silver ETF was last seen trading 2.8% lower, while the iShares Silver Trust ETF was down by 1.4%. First Majestic Silver shed 3.8%, while Hecla Mining was 3.1% lower. Stocks in Europe and Asia were broadly lower in their respective trading sessions, while U.S. equity futures fell ahead of Wall Street's regular session. Bitcoin also came under further pressure, losing around 1.3% to trade at $61,049.25. Stock Chart Icon Stock chart icon Bitcoin Ewa Manthey, a commodities strategist at ING, told CNBC that gold and silver are coming under pressure as market focus shifts back to rates and inflation rather than pure safe-haven demand. "The escalation in the Middle East is pushing oil higher and lifting inflation risks, which in turn is reinforcing expectations that central banks stay tighter for longer," she said. "That's pushing real yields higher — a clear headwind for non-yielding assets like gold and silver." Money markets are currently pricing in a 98.2% chance that the Fed holds its key interest rate steady at its FOMC meeting next week, according to the CME's FedWatch tool. Traders now see a roughly 40% chance of a hike by the Fed's October meeting. The ECB is also overwhelmingly expected to raise interest rates by 25 basis poin...
matdesign24/iStock via Getty Images Co-authored with Beyond Saving. Are you prepared to manage your own portfolio? Many people take a passive route to investing while they are working. They don't have time, so they throw their 401(k) money into a few funds recommended by the company operating their 401(k). Then retirement comes; now what? Hire an adviser and hope they are good? Throw some money in...
matdesign24/iStock via Getty Images Co-authored with Beyond Saving. Are you prepared to manage your own portfolio? Many people take a passive route to investing while they are working. They don't have time, so they throw their 401(k) money into a few funds recommended by the company operating their 401(k). Then retirement comes; now what? Hire an adviser and hope they are good? Throw some money into a few index funds? Buy a bigger mattress? Many people decide they want to manage their own money. I believe that is a great option, but it is one that comes with potential pitfalls. Today, I want to talk about three common risks that people face when they start investing. Risk #1: You Aren't As Rich As You Think You Are You open up your brokerage account, and today it is likely within a stone's throw of the largest number you've ever seen in it. That brings a feeling of comfort - your nest egg is intact, and everything is right in the world. So you go about your life whistling while you mosey down to the golf course, the smell of fresh-cut grass, and the warmth of the rising sun on your face. Retirement is great! Does that describe you? Now imagine you open up your brokerage account in the morning, and you see a number that is 20, 30, or even 50% lower. Are you still whistling on your way to the golf course, confident that your future is secure? For a lot of people, the answer to that question is "no," and that's a problem. Because your portfolio is going to decline, it is only a matter of time. Stock market drawdowns are a normal, routine, and expected behavior for the market. Here is a look at drawdowns in the S&P 500 ( SP500 ) as measured by VFINX: Source . Portfolio Visualizer And this is how much your portfolio comes down when you aren't taking any money out of it to live off of. Note that it has been a good 17 years since the market had a major meltdown. The dips that we saw during COVID and the 2022 bear market were mild and brief relative to what we've seen in hi...
In recent trading, shares of Kite Realty Group Trust (Symbol: KRG) have crossed above the average analyst 12-month target price of $28.18, changing hands for $28.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade
In recent trading, shares of Kite Realty Group Trust (Symbol: KRG) have crossed above the average analyst 12-month target price of $28.18, changing hands for $28.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade
PhonlamaiPhoto/iStock via Getty Images Agentic finance firm ProCap Financial ( BRR ) has partnered with Ornn AI to gain access to Ornn's proprietary compute pricing data for use in its ProCap Insights service, the companies said Wednesday. The growing demand for compute, one of the largest costs in the AI buildout, makes understanding its price, availability, and market dynamics more important for...
PhonlamaiPhoto/iStock via Getty Images Agentic finance firm ProCap Financial ( BRR ) has partnered with Ornn AI to gain access to Ornn's proprietary compute pricing data for use in its ProCap Insights service, the companies said Wednesday. The growing demand for compute, one of the largest costs in the AI buildout, makes understanding its price, availability, and market dynamics more important for investors. ProCap Insights provides independent investors data and analysis that help translate compute market trends into actionable investment insights, the company said. "With Ornn’s data, our AI agents will be able to track the price of compute and develop research independent investors can use to make more informed investment decisions," said Phil Rosen , chief market strategist at ProCap Financial. More on ProCap Financial, Inc. ProCap Financial repurchases 2M shares after selling ~52 BTC Anthony Pompliano's ProCap to launch unit focused on AI-generated research reports Financial information for ProCap Financial, Inc.
In recent trading, shares of Tanger Inc (Symbol: SKT) have crossed above the average analyst 12-month target price of $38.82, changing hands for $39.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,
In recent trading, shares of Tanger Inc (Symbol: SKT) have crossed above the average analyst 12-month target price of $38.82, changing hands for $39.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,
In recent trading, shares of Douglas Emmett Inc (Symbol: DEI) have crossed above the average analyst 12-month target price of $12.60, changing hands for $12.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va
In recent trading, shares of Douglas Emmett Inc (Symbol: DEI) have crossed above the average analyst 12-month target price of $12.60, changing hands for $12.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va
Asia-Pacific cities account for 39 per cent of the top global financial services companies and about 36 per cent of the world’s leading financial centres, Colliers said. Supported by strong labour markets and venture capital activity, cities such as Singapore, Beijing, Shanghai and Hong Kong ranked among the region’s top talent hubs. However, New York emerged as the clear leader in the property co...
Asia-Pacific cities account for 39 per cent of the top global financial services companies and about 36 per cent of the world’s leading financial centres, Colliers said. Supported by strong labour markets and venture capital activity, cities such as Singapore, Beijing, Shanghai and Hong Kong ranked among the region’s top talent hubs. However, New York emerged as the clear leader in the property consultant’s report, scoring 4.6 out of a possible 5, followed by London with a mark of 3.9 and...
In recent trading, shares of Enpro Inc (Symbol: NPO) have crossed above the average analyst 12-month target price of $327.00, changing hands for $329.43/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation
In recent trading, shares of Enpro Inc (Symbol: NPO) have crossed above the average analyst 12-month target price of $327.00, changing hands for $329.43/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation
Carl Icahn lowered his active stake in JetBlue Airways Corporation ( JBLU ) to 5.55% following the sale of 4,331,821 shares during the period from June 1 to June 9. The disclosure was made through various SEC filings made from Icahn entities, including Icahn Enterprises L.P. ( IEP ). Icahn began buying JetBlue (JBLUE) shares in January of 2024, building a position for what he said was an "attracti...
Carl Icahn lowered his active stake in JetBlue Airways Corporation ( JBLU ) to 5.55% following the sale of 4,331,821 shares during the period from June 1 to June 9. The disclosure was made through various SEC filings made from Icahn entities, including Icahn Enterprises L.P. ( IEP ). Icahn began buying JetBlue (JBLUE) shares in January of 2024, building a position for what he said was an "attractive investment opportunity." His stake went as high as 9.9%, and he landed two of his representatives on the JetBlue ( JBLU ) board. Shares of JetBlue ( JBLU ) were down 2.3% in premarket trading amid broad selling in the airline sector due to renewed hostilities between the U.S. and Iran. The airline stock is only up slightly from the level that Icahn first snapped up shares. More on JetBlue Airways JetBlue: No Imminent Bankruptcy Risk Here JetBlue Airways Corporation (JBLU) Q1 2026 Earnings Call Transcript JetBlue Airways Corporation 2026 Q1 - Results - Earnings Call Presentation JetBlue downgraded by S&P further into 'junk' status SA analyst upgrades/downgrades: MU, JBLU, PYPL, ORCL
In recent trading, shares of WillScot Holdings Corp (Symbol: WSC) have crossed above the average analyst 12-month target price of $27.11, changing hands for $27.53/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o
In recent trading, shares of WillScot Holdings Corp (Symbol: WSC) have crossed above the average analyst 12-month target price of $27.11, changing hands for $27.53/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o
Torsten Asmus/iStock via Getty Images I believe that Seeking Alpha is home to some of the sharpest, most dedicated, income-focused analysts in the financial community. For income investors who need to generate cash flow to meet living expenses, the research published here on high-yield funds is invaluable. To be clear, I am not some index devotee who believes high-yield vehicles have no place in a...
Torsten Asmus/iStock via Getty Images I believe that Seeking Alpha is home to some of the sharpest, most dedicated, income-focused analysts in the financial community. For income investors who need to generate cash flow to meet living expenses, the research published here on high-yield funds is invaluable. To be clear, I am not some index devotee who believes high-yield vehicles have no place in a portfolio. I have owned many of the exact funds or similar ones that I will discuss here. However, I have always approached these assets strictly as a tactical allocator, not as a blind buy-and-hold forever yield seeker. During extended bull markets, there is a dangerous confirmation bias that seems to take hold in the income investing space. To an investor, a large double-digit monthly distribution acts like a siren song. The investor is mesmerized while blinded to the mathematical reality of structured net asset value (NAV) decay, the actual cost of internal leverage, and the potential for permanent wealth destruction that may occur when paying steep premiums late in the market cycle. In this article, I play a respectful but serious devil's advocate as I look back at the market's stress test of some of retail investors' favorite high-yielding funds. This article will feature some heavyweights of the fixed income universe, including highly leveraged debt funds like PIMCO Corporate & Income Opportunity Fund ( PTY ), Guggenheim Strategic Opportunities Fund ( GOF ), and BlackRock Corporate High Yield Fund, Inc. ( HYT ). Performance and risk metrics were calculated utilizing adjusted price histories for each fund within my study. The Drawdown Buyer Methodology The core of my thesis is that these complex, often leveraged income vehicles are poorly suited for passive accumulation near all-time highs. Because these instruments carry equity-like risk that belies many investors' sense of the theoretically stable underlying assets (e.g., bonds), it is safer to buy such funds during...
Oracle Corporation will release earnings for its fourth quarter after the closing bell on Wednesday, June 10. Analysts expect the company to report quarterly earnings of $1.96 per share, up from $1.70 per share in the year-ago period. The consensus...
Oracle Corporation will release earnings for its fourth quarter after the closing bell on Wednesday, June 10. Analysts expect the company to report quarterly earnings of $1.96 per share, up from $1.70 per share in the year-ago period. The consensus...